Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Progression of fibrosing interstitial lung disease.

Wong AW, Ryerson CJ, Guler SA.

Respir Res. 2020 Jan 29;21(1):32. doi: 10.1186/s12931-020-1296-3. Review.

2.

Kissed by MDA-5: lobular panniculitis of the cheek as an initial symptom of dermatomyositis.

Galli S, Naudi G, Guler SA, Genitsch V, Cullmann J, Stefanski AL, Kollert F.

Rheumatology (Oxford). 2019 Nov 29. pii: kez567. doi: 10.1093/rheumatology/kez567. [Epub ahead of print] No abstract available.

PMID:
31782785
3.

Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.

Guler SA, Kwan JM, Leung JM, Khalil N, Wilcox PG, Ryerson CJ.

Eur Respir J. 2020 Jan 23;55(1). pii: 1900647. doi: 10.1183/13993003.00647-2019. Print 2020 Jan. Erratum in: Eur Respir J. 2020 Mar 26;55(3):.

PMID:
31537699
4.

New radiological diagnostic criteria: impact on idiopathic pulmonary fibrosis diagnosis.

Funke-Chambour M, Guler SA, Geiser T, Christe A, Heverhagen J, Pöllinger A, Huber A, Ebner L.

Eur Respir J. 2019 Nov 7;54(5). pii: 1900905. doi: 10.1183/13993003.00905-2019. Print 2019 Nov. No abstract available.

PMID:
31273039
5.

Impact of Psychological Deficits and Pain on Physical Activity of Patients with Interstitial Lung Disease.

Hur SA, Guler SA, Khalil N, Camp PG, Guenette JA, Ryerson CJ.

Lung. 2019 Aug;197(4):415-425. doi: 10.1007/s00408-019-00242-3. Epub 2019 Jun 1.

PMID:
31154459
6.

Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study.

Guler SA, Hur SA, Lear SA, Camp PG, Ryerson CJ.

Respir Res. 2019 Mar 12;20(1):56. doi: 10.1186/s12931-019-1019-9.

7.

A Very Rare Reason for Gastric Perforation, Caused by Gastric Metastasis of Breast Cancer: Case Presentation.

Güler SA, Şimşek T, Pösteki G, Güreşin A, Çınar S, Onbaşılar U, Cantürk NZ.

Eur J Breast Health. 2018 Nov 21;15(1):59-62. doi: 10.5152/ejbh.2018.4285. eCollection 2019 Jan.

8.

Complications Associated with Loco-Regional Treatment of Breast Cancer and Their Impact on Quality-of-Life.

Özçınar B, Güler SA, Kocaman N, Özkan M, Güllüoğlu BM, Özmen V.

Eur J Breast Health. 2018 Oct 24;15(1):51-58. doi: 10.5152/ejbh.2018.4198. eCollection 2019 Jan.

9.

Cutaneous adverse effects of methylene blue in an animal skin-flap model.

Güler SA, Kırnaz S, Şimşek T, Demir Cİ, Güneş A, İşken T, Cantürk NZ, Utkan NZ.

Acta Chir Belg. 2019 Feb 6:1-6. doi: 10.1080/00015458.2019.1570742. [Epub ahead of print]

PMID:
30724704
10.

YouTube Videos as a Source of Misinformation on Idiopathic Pulmonary Fibrosis.

Goobie GC, Guler SA, Johannson KA, Fisher JH, Ryerson CJ.

Ann Am Thorac Soc. 2019 May;16(5):572-579. doi: 10.1513/AnnalsATS.201809-644OC.

PMID:
30608877
11.

Antifibrotics: Shrinking the Box of Therapeutic Uncertainty.

Guler SA, Funke-Chambour M.

Respiration. 2019;97(3):202-204. doi: 10.1159/000494275. Epub 2018 Nov 19. No abstract available.

PMID:
30453286
12.

Relationship of functional constipation and anal-retentive behavior features.

Yılmaz TU, Taş Hİ, Uçar E, Cerit C, Çelebi A, Güler SA, Utkan Z.

Turk J Surg. 2018 Sep 21:1-5. doi: 10.5152/turkjsurg.2018.4035. [Epub ahead of print]

PMID:
30269755
13.

Does hyperthermic preconditioning affect the rate of surgical site infection rate and inflammatory reaction in colorectal cancer patients? A prospective randomized clinical trial.

Attaallah W, Şen LS, Aktan AÖ, Ekşioğlu ED, Eti Z, Güler SA, Cingi A.

Turk J Surg. 2018 Sep 11;34(4):282-285. doi: 10.5152/turkjsurg.2018.3981.

14.

Obesity and Bariatric Surgery awareness in the Kocaeli province, a leading industrial city in Turkey.

Güler SA, Yılmaz TU, Şimşek T, Yirmibeşoğlu O, Kırnaz S, Utkan NZ, Cantürk NZ.

Turk J Surg. 2018 Aug 28;34(3):165-168. doi: 10.5152/turkjsurg.2018.3871.

15.

Minimal Important Difference for Physical Activity and Validity of the International Physical Activity Questionnaire in Interstitial Lung Disease.

Hur SA, Guler SA, Khalil N, Camp PG, Guenette JA, Swigris JJ, Ryerson CJ.

Ann Am Thorac Soc. 2019 Jan;16(1):107-115. doi: 10.1513/AnnalsATS.201804-265OC.

PMID:
30211616
16.

Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression.

Guler SA, Winstone TA, Murphy D, Hague C, Soon J, Sulaiman N, Li KH, Dunne J, Wilcox PG, Ryerson CJ.

Ann Am Thorac Soc. 2018 Dec;15(12):1427-1433. doi: 10.1513/AnnalsATS.201806-362OC.

PMID:
30188737
17.

Unclassifiable interstitial lung disease: from phenotyping to possible treatments.

Guler SA, Ryerson CJ.

Curr Opin Pulm Med. 2018 Sep;24(5):461-468. doi: 10.1097/MCP.0000000000000509. Review.

18.

Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-Analysis.

Guler SA, Ellison K, Algamdi M, Collard HR, Ryerson CJ.

Ann Am Thorac Soc. 2018 Jul;15(7):854-863. doi: 10.1513/AnnalsATS.201801-067OC.

PMID:
29779392
19.

Scoring Idiopathic Granulomatous Mastitis: An Effective System for Predicting Recurrence?

Yılmaz TU, Gürel B, Güler SA, Baran MA, Erşan B, Duman S, Utkan Z.

Eur J Breast Health. 2018 Apr 1;14(2):112-116. doi: 10.5152/ejbh.2018.3709. eCollection 2018 Apr.

20.

Characteristics of Special Type Breast Tumors in Our Center.

Yılmaz TU, Trabzonlu L, Güler SA, Baran MA, Pösteki G, Erçin C, Utkan Z.

Eur J Breast Health. 2018 Jan 1;14(1):17-22. doi: 10.5152/ejbh.2017.3219. eCollection 2018 Jan.

21.

Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.

Guler SA, Kwan JM, Winstone TA, Milne KM, Dunne JV, Wilcox PG, Ryerson CJ.

Respir Med. 2017 Aug;129:1-7. doi: 10.1016/j.rmed.2017.05.012. Epub 2017 May 25.

22.

Proteomics Analysis of Tissue Samples Reveals Changes in Mitochondrial Protein Levels in Parathyroid Hyperplasia over Adenoma.

Akpinar G, Kasap M, Canturk NZ, Zulfigarova M, Islek EE, Guler SA, Simsek T, Canturk Z.

Cancer Genomics Proteomics. 2017 May-Jun;14(3):197-211.

23.

Impact of cyclooxygenase-2 over-expression on the prognosis of breast cancer patients.

Güler SA, Uğurlu MÜ, Kaya H, Şen S, Nazlı Y, Güllüoğlu BM.

Ulus Cerrahi Derg. 2015 Jun 1;32(2):81-8. doi: 10.5152/UCD.2016.3146. eCollection 2016.

24.

Multidisciplinary discussion for diagnosis of interstitial lung disease in real life.

Guler SA, Berezowska SA, Christe A, Geiser T, Funke-Chambour M.

Swiss Med Wkly. 2016 Jun 1;146:w14318. doi: 10.4414/smw.2016.14318. eCollection 2016. No abstract available.

25.

Distribution and predominance of genotype 3 in hepatitis C virus carriers in the province of kahramanmaras, Turkey.

Caliskan A, Kirisci O, Ozkaya E, Ozden S, Tumer S, Caglar S, Guler SA, Senol H.

Hepat Mon. 2015 Apr 25;15(4):e25142. doi: 10.5812/hepatmon.15(4)2015.25142. eCollection 2015 Apr.

26.

Multidisciplinary breast cancer teams and proposed standards.

Güler SA, Cantürk NZ.

Ulus Cerrahi Derg. 2014 Oct 20;31(1):39-41. doi: 10.5152/UCD.2014.2724. eCollection 2015. Review.

27.

Giant nasolabial cyst.

Sagiroglu SG, Guler SA.

J Pak Med Assoc. 2014 Nov;64(11):1320-1.

28.

Five-Year Disease-Free Follow-Up of a Borderline Breast Phyllodes Tumor in a 15-year-old Patient.

Güler SA, Uğurlu MÜ, Güllüoğlu BM.

J Breast Health. 2015 Jul 1;11(3):138-140. doi: 10.5152/tjbh.2015.2146. eCollection 2015 Jul.

29.

Evaluation of pulmonary and extrapulmonary tuberculosis in immunocompetent adults: a retrospective case series analysis.

Guler SA, Bozkus F, Inci MF, Kokoglu OF, Ucmak H, Ozden S, Yuksel M.

Med Princ Pract. 2015;24(1):75-9. doi: 10.1159/000365511. Epub 2014 Oct 17.

30.

The emerging role of national academies in surgical training: an inspiring environment for increasing the quality of health care in breast cancer management.

Yilmaz OC, Cantürk NZ, Kebudi A, Güler SA, Erkek A, Rezai M, Güllüoğlu BM.

J Cancer Educ. 2014 Jun;29(2):395-400. doi: 10.1007/s13187-014-0626-x.

PMID:
24515563
31.

Quality Assurance in Breast Health Care and Requirement for Accreditation in Specialized Units.

Güler SA, Güllüoğlu BM.

J Breast Health. 2014 Jul 1;10(3):129-133. doi: 10.5152/tjbh.2014.1797. eCollection 2014 Jul. Review.

32.

Laparoscopic treatment of ileal intussusception due to heterotopic gastric mucosa in an adult patient.

Yılmaz TU, Güneş A, Pösteki G, Güler SA.

Ulus Cerrahi Derg. 2014 Mar 1;30(1):60-1. doi: 10.5152/UCD.2014.2464. eCollection 2014.

33.

Efficacy of prophylactic antibiotic administration for breast cancer surgery in overweight or obese patients: a randomized controlled trial.

Gulluoglu BM, Guler SA, Ugurlu MU, Culha G.

Ann Surg. 2013 Jan;257(1):37-43. doi: 10.1097/SLA.0b013e31826d832d.

PMID:
23001082
34.

Breast cancer related lymphedema in patients with different loco-regional treatments.

Ozcinar B, Guler SA, Kocaman N, Ozkan M, Gulluoglu BM, Ozmen V.

Breast. 2012 Jun;21(3):361-5. doi: 10.1016/j.breast.2012.03.002. Epub 2012 Mar 27.

Supplemental Content

Loading ...
Support Center